Search - tctmd.com

Displaying 21 - 40 of 151

Sort: Relevancy | Date

Presentation Cell Therapy 2014

PERFECT-Phase III Clinical TrialKey Study Elements

Presenter: Gustav Steinhoff

January 22, 2014

Presentation Cell Therapy 2014

MPC’s for Ischemic and Non-ischemic Heart Failure

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

LV Augmentation for the Treatment of Heart Failure

Presenter: Randy Lee

January 22, 2014

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

Presentation Cell Therapy 2014

HGF for Critical Limb Ischemia

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

Gene Modified EPCs for STEMI

Presenter: Michael Kutryk

January 22, 2014

Presentation Cell Therapy 2014

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Presenter: Joseph C. Wu

January 22, 2014

Presentation Cell Therapy 2014

Enabling Full Automation of Cell Processing

Presenter: Normand Pilon

January 22, 2014

Presentation Cell Therapy 2014

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

Presenter: Hyo-Soo Kim

January 22, 2014

Presentation Cell Therapy 2014

CXCR4 AnTagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

Presenter: Jonathan Hill

January 22, 2014

Presentation Cell Therapy 2014

Connexin 43 transfected skeletal myoblasts in patients with CHF

Presenter: Maciej Kurpisz

January 22, 2014

Presentation Cell Therapy 2014

Clinical Trials in Peripheral Arterial Disease

Presenter: Keith L. March

January 22, 2014

Presentation Cell Therapy 2014

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

Presenter: Marc S. Penn

January 22, 2014

Presentation Cell Therapy 2014

Cardiosphere Derived Cells for Myocardial Repair: CADUCEUS and ALLSTAR programs

Presenter: Raj R. Makkar

January 22, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation Cell Therapy 2014

Aastrom Company Overview

Presenter: David Recker

January 22, 2014

Presentation Cell Therapy 2014

12 months CMR and long-term clinical results of the Swiss AMI Study

Presenter: Daniel S?rder

January 22, 2014

Presentation Cell Therapy 2014

Ventrix Solutions for the Heart

Presenter: Paul Chamberlin

January 21, 2014

Presentation Cell Therapy 2014

The promise of biomaterial delivery vehicles for improving stem cell retention in the infarcted heart

Presenter: Ellen Roche

January 21, 2014

Presentation Cell Therapy 2014

Stem Cell & SDF-1/CXCR4 In Diabetes

Presenter: Feng Dong

January 21, 2014

Advertisement

PERFECT-Phase III Clinical TrialKey Study Elements

MPC’s for Ischemic and Non-ischemic Heart Failure

LV Augmentation for the Treatment of Heart Failure

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

HGF for Critical Limb Ischemia

Gene Modified EPCs for STEMI

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Enabling Full Automation of Cell Processing

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

CXCR4 AnTagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

Connexin 43 transfected skeletal myoblasts in patients with CHF

Clinical Trials in Peripheral Arterial Disease

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

Cardiosphere Derived Cells for Myocardial Repair: CADUCEUS and ALLSTAR programs

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Aastrom Company Overview

12 months CMR and long-term clinical results of the Swiss AMI Study

Ventrix Solutions for the Heart

The promise of biomaterial delivery vehicles for improving stem cell retention in the infarcted heart

Stem Cell & SDF-1/CXCR4 In Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content